PROPANC BIOPHARMA, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROPANC BIOPHARMA, INC. stock issued during period, shares, new issues for the quarter ending 2022-06-30 was 38.20M shares.
- PROPANC BIOPHARMA, INC. stock issued during period, shares, new issues for the quarter ending 2022-03-31 was 9.80M shares, a 322.90% increase year-over-year.
- PROPANC BIOPHARMA, INC. stock issued during period, shares, new issues for the quarter ending 2021-12-31 was 6.40M shares.
- PROPANC BIOPHARMA, INC. stock issued during period, shares, new issues for the quarter ending 2021-09-30 was 2.40M shares, a 99.46% decline year-over-year.
- PROPANC BIOPHARMA, INC. stock issued during period, shares, new issues for fiscal 2022 was 56.80M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2022-06-30 | 38.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | 56.80M shares 10-K · filed 2022-09-28 |
| 2022-03-31 | 9.80M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | |
| 2021-12-31 | 6.40M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | |
| 2021-09-30 | 2.40M shares 10-Q · filed 2021-11-12 | |
| 2021-03-31 | 2.32M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | |
| 2020-12-31 | -440.89M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | |
| 2020-09-30 | 442.03M shares 10-Q · filed 2020-11-16 | |
| 2020-03-31 | 16.10M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | |
| 2019-12-31 | 1.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | |
| 2019-09-30 | 181.94K shares 10-Q · filed 2019-11-14 | |
| 2017-06-30 | 130.00K shares 10-Q · filed 2018-05-10 | |
| 2016-06-30 | 130.00K shares 10-Q · filed 2018-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |